|
The Phase I/II Trials Collaborative for Children, Adolescents, and Young Adults at UH Rainbow Babies & Children's Hospital and the Case Comprehensive Cancer Center |
Case Western Reserve University |
Flashes of Hope |
|
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute |
Cure4Cam Childhood Cancer Foundation |
|
Children's Hospital Colorado Experimental Therapeutics Program |
Children’s Hospital Colorado |
Northwestern Mutual Foundation |
|
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute |
I Care I Cure |
|
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma
|
Beckman Research Institute of City of Hope |
I Care I Cure |
|
B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers
|
University of Texas Southwestern Medical Center |
Cure4Cam Childhood Cancer Foundation |
|
Novel STAT3 drug development for childhood osteosarcoma therapy using drug repositioning |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope |
|
A novel mouse model of rhabdomyosarcoma |
Vanderbilt University Medical Center |
I Care I Cure |
